129 related articles for article (PubMed ID: 37017984)
1. Patient Perspectives of Health System Barriers to Accessing Care for Hidradenitis Suppurativa: A Qualitative Study.
Barnes LA; Shukla N; Paul M; de Vere Hunt I; Halley MC; Linos E; Naik HB
JAMA Dermatol; 2023 May; 159(5):510-517. PubMed ID: 37017984
[TBL] [Abstract][Full Text] [Related]
2. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
[TBL] [Abstract][Full Text] [Related]
3. Assessing unmet needs in patients with hidradenitis suppurativa.
Chadha SA; Stout MA; Goyal PK; Nguyen CV; Lu KQ
Arch Dermatol Res; 2023 Nov; 315(9):2555-2560. PubMed ID: 37264285
[TBL] [Abstract][Full Text] [Related]
4. A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care.
Jalbert I; Rahardjo D; Yashadhana A; Liew G; Gopinath B
PLoS One; 2020; 15(2):e0228858. PubMed ID: 32045445
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Experiences of Autistic Transgender and Non-Binary Adults in Seeking Gender Identity Health Care.
Bruce H; Munday K; Kapp SK
Autism Adulthood; 2023 Jun; 5(2):191-203. PubMed ID: 37346990
[TBL] [Abstract][Full Text] [Related]
7. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
8. What matters to people with chronic conditions when accessing care in Australian general practice? A qualitative study of patient, carer, and provider perspectives.
Song HJ; Dennis S; Levesque JF; Harris MF
BMC Fam Pract; 2019 Jun; 20(1):79. PubMed ID: 31182041
[TBL] [Abstract][Full Text] [Related]
9. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
[TBL] [Abstract][Full Text] [Related]
10. Patient experiences with hidradenitis suppurativa: the Hidradenitis Patient Experience survey.
Kashetsky N; Mukovozov IM; Pereira J; Manion R; Carter S; Alhusayen R
Clin Exp Dermatol; 2022 Jan; 47(1):72-79. PubMed ID: 34235774
[TBL] [Abstract][Full Text] [Related]
11. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
12. Access to CKD Care in Rural Communities of India: a qualitative study exploring the barriers and potential facilitators.
Jafar TH; Ramakrishnan C; John O; Tewari A; Cobb B; Legido-Quigley H; Sungwon Y; Jha V
BMC Nephrol; 2020 Jan; 21(1):26. PubMed ID: 31996168
[TBL] [Abstract][Full Text] [Related]
13. How Do Orthopaedic Providers Conceptualize Good Patient Outcomes and Their Barriers and Facilitators After Acute Injury? A Qualitative Study.
Doorley JD; Fishbein NS; Greenberg J; Reichman M; Briskin EA; Bakhshaie J; Vranceanu AM
Clin Orthop Relat Res; 2023 Jun; 481(6):1088-1100. PubMed ID: 36346734
[TBL] [Abstract][Full Text] [Related]
14. Patients' perspectives of facilitators and barriers to patient-centred care: insights from qualitative patient interviews.
Vennedey V; Hower KI; Hillen H; Ansmann L; Kuntz L; Stock S;
BMJ Open; 2020 May; 10(5):e033449. PubMed ID: 32376748
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.
Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE
PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827
[TBL] [Abstract][Full Text] [Related]
16. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
Kucinskiene V; Jariene V; Valiukeviciene S
Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
[TBL] [Abstract][Full Text] [Related]
18. Patient and Clinician Perspectives of a Standardized Question About Firearm Access to Support Suicide Prevention: A Qualitative Study.
Richards JE; Kuo ES; Whiteside U; Shulman L; Betz ME; Parrish R; Boggs JM; Rowhani-Rahbar A; Simon GE
JAMA Health Forum; 2022 Nov; 3(11):e224252. PubMed ID: 36416815
[TBL] [Abstract][Full Text] [Related]
19. Differences Between Children and Adults With Hidradenitis Suppurativa.
Hallock KK; Mizerak MR; Dempsey A; Maczuga S; Kirby JS
JAMA Dermatol; 2021 Sep; 157(9):1095-1101. PubMed ID: 34379074
[TBL] [Abstract][Full Text] [Related]
20. Hair salons and stylist-client social relationships as facilitators of community-based contraceptive uptake in KwaZulu-Natal, South Africa: a qualitative analysis.
Wara NJ; Psaros C; Govere S; Dladla N; Stuckwisch A; Zionts D; Jarolimova J; Bassett IV
Reprod Health; 2021 Aug; 18(1):178. PubMed ID: 34461925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
